• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TFC
Click for more information
7.42% $1.31

TFS CORPORATION LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
TFCTFS Sandalwood Project 2014 Product Ruling27/02/14
TFCHalf Year 2014 Financial Results Investor Presentation26/02/14
TFCInterim Results - Six Months of Significant Progress26/02/14
TFCHalf Year Accounts26/02/14
TFCAppendix 4D for the Half Year Ended 31 December 2013PRICE SENSITIVE26/02/14
TFCNew Agreements with Global Pharmaceutical CompanyPRICE SENSITIVE26/02/14
TFCTrading HaltPRICE SENSITIVE25/02/14
TFCViroxis Completes Clinical Study Using TFS Sandalwood OilPRICE SENSITIVE18/02/14
TFCSettlement of Transaction with US Institutional Investor14/02/14
TFCNo Plantation Damage From Kununurra Floods14/02/14
TFCConditional N.T. Land PurchasePRICE SENSITIVE20/12/13
TFCUn-audited Financial Report for the 3 months ended 30.09.13PRICE SENSITIVE29/11/13
TFCResults of Meeting15/11/13
TFCCEO Presentation - AGM15/11/13
TFCChairman's Address - AGM15/11/13
TFCAppointment of New Chief Financial Officer12/11/13
TFCWithdrawal of Resolution 3 - Performance Rights Plan11/11/13
TFCAppendix 3B08/11/13
TFCWholesale Settlement of $49 millionPRICE SENSITIVE25/10/13
TFCPresentation to Australian Microcap Investment Conference22/10/13
TFCCeasing to be a substantial holder10/10/13
TFCAnnual General Meeting and Notice10/10/13
TFCNotice of Annual General Meeting/Proxy Form09/10/13
TFCAnnual Report to shareholders07/10/13
TFCHarvest and Pharmaceutical Development UpdatePRICE SENSITIVE01/10/13
TFCInitial Director's Interest Notice x117/09/13
TFCIndependent Non - Executive Chairman Commences with TFS17/09/13
TFCAnnual Financial Statements13/09/13
TFCFIRST HARVEST UPDATEPRICE SENSITIVE09/09/13
TFCInvestor Presentation02/09/13
TFCNON-EXECUTIVE CHAIRMAN APPOINTMENT29/08/13
TFCFIRST HARVEST UPDATEPRICE SENSITIVE29/08/13
TFCPROFIT INCREASE & DIVIDEND REINSTATED29/08/13
TFCPreliminary Financial Report for the year ended 30 June 2013PRICE SENSITIVE29/08/13
TFCChange in substantial holding23/07/13
TFCAppendix 3Y - Change of Director's Interest Notice03/07/13
TFCAmended Share Trading Policy02/07/13
TFCSales up 132% and Strategic Review OutcomesPRICE SENSITIVE02/07/13
TFCUS Institution Exercises Second OptionPRICE SENSITIVE27/06/13
TFCMarket UpdatePRICE SENSITIVE26/06/13
TFCAppendix 3Y - Change of Director's Interest Notice06/06/13
TFCResponse to ASX Price and Volume QueryPRICE SENSITIVE05/06/13
TFCUn-audited Financial Report for the 9 months ended 31.03.1331/05/13
TFCUNAUDITED FINANCIAL RESULTS FOR THE 9 MONTHS ENDING 31.03.13PRICE SENSITIVE31/05/13
TFCAppendix 3Y - Change of Director's Interest Notice14/05/13
TFCDivestment of Portfolio of MIS Loans01/05/13
TFCBecoming a substantial holder12/04/13
TFCPharmaceutical Product Development with US PartnersPRICE SENSITIVE11/04/13
TFCMarket UpdatePRICE SENSITIVE21/03/13
TFCIndustry Leader for Ethical and Sustainable Practice13/03/13
TFCHalf Year Financial Results and Market Update28/02/13
TFCAppendix 4D - Half Year Financial ReportPRICE SENSITIVE28/02/13
TFCAppendix 3Y - Change of Director's Interest Notice30/01/13
TFCAppendix 3Y - Change of Director's Interest Notice23/01/13
TFCMarket UpdatePRICE SENSITIVE16/01/13
TFCAppendix 3Y - Change of Director's Interest Notice14/01/13
TFCShareholder UpdatePRICE SENSITIVE20/12/12
TFCMIS Product Ruling for 201312/12/12
TFCMarket UpdatePRICE SENSITIVE03/12/12
TFCUnaudited September Quarter ResultsPRICE SENSITIVE03/12/12
TFCUnaudited Quarterly Financial Report - Quarter Ended 30091203/12/12
TFCExtract of AGM Chairman's AddressPRICE SENSITIVE16/11/12
TFCResults of Meeting16/11/12
TFCRequisition NoticePRICE SENSITIVE12/11/12
TFCAppendix 3Y - Change of Director's Interest Notice18/10/12
TFCNotice of Annual General Meeting/Proxy Form17/10/12
TFCAppendix 3Z Final Directors Interest Notice03/10/12
TFCRESIGNATION OF CHAIRMAN03/10/12
TFCUpdated Investor Presentation02/10/12
TFC2012 Annual Report28/09/12
TFCInvestor Presentation13/09/12
TFCBOARD APPOINT MOELIS & COMPANY TO ASSIST ON STRATEGIC REVIEW06/09/12
TFCFULL YEAR RESULTS TO 30 JUNE 2012 AND MARKET UPDATEPRICE SENSITIVE31/08/12
TFCAPPENDIX 4E - Preliminary Financial ReportPRICE SENSITIVE31/08/12
TFCAppendix 3X - Initial Director's Interest Notice12/07/12
TFCAppendix 3Z - Final Director's Interest Notice12/07/12
TFCAppendix 3Z - Final Director's Interest Notice12/07/12
TFCTFS DIRECTOR MOVEMENTS AND WHOLESALE SETTLEMENT12/07/12
TFCMIS SALES RESULTPRICE SENSITIVE02/07/12
TFCRELEASE OF FUNDS IN ESCROW26/06/12
TFCAppendix 3X - Initial Director's Interest Notice14/06/12
TFCChanges to the Board of Directors14/06/12
TFCChange in substantial holding05/06/12
TFCUn-audited Financial Report for the 9 months ended 31 Mar 12PRICE SENSITIVE30/05/12
TFCTFS REPORTS UNAUDITED FINANCIAL RESULTS - MARCH QUARTER FY12PRICE SENSITIVE30/05/12
TFCMARKET UPDATEPRICE SENSITIVE21/03/12
TFCAppendix 3Y02/03/12
TFCChange of Director's Interest Notice01/03/12
TFC1H12 Results Presentation29/02/12
TFCAPPENDIX 4D - Half Year Financial ReportPRICE SENSITIVE29/02/12
TFCHALF YEAR RESULTS TO 31 DECEMBER 201129/02/12
TFCFURTHER LAND ACQUISITIONS AND UPDATEPRICE SENSITIVE20/01/12
TFCMarket UpdatePRICE SENSITIVE03/01/12
TFCAppendix 3X - J Matthys03/01/12
TFCAppendix 3Z - J Craig03/01/12
TFCTFS ViroXis UpdatePRICE SENSITIVE28/12/11
TFCFURTHER LAND ACQUISITIONS AND BOARD CHANGESPRICE SENSITIVE23/12/11
TFCTFS REPORTS UNAUDITED SEPTEMBER QUARTER FINANCIAL RESULTS30/11/11
TFCUn-audited September 2011 Quarterly Financial ReportPRICE SENSITIVE30/11/11
TFCChange in substantial holding16/11/11
TFCTFS Sandalwood Project 2014 Product Ruling
27/02/14
TFCHalf Year 2014 Financial Results Investor Presentation
26/02/14
TFCInterim Results - Six Months of Significant Progress
26/02/14
TFCHalf Year Accounts
26/02/14
TFCAppendix 4D for the Half Year Ended 31 December 2013
26/02/14PRICE SENSITIVE
TFCNew Agreements with Global Pharmaceutical Company
26/02/14PRICE SENSITIVE
TFCTrading Halt
25/02/14PRICE SENSITIVE
TFCViroxis Completes Clinical Study Using TFS Sandalwood Oil
18/02/14PRICE SENSITIVE
TFCSettlement of Transaction with US Institutional Investor
14/02/14
TFCNo Plantation Damage From Kununurra Floods
14/02/14
TFCConditional N.T. Land Purchase
20/12/13PRICE SENSITIVE
TFCUn-audited Financial Report for the 3 months ended 30.09.13
29/11/13PRICE SENSITIVE
TFCResults of Meeting
15/11/13
TFCCEO Presentation - AGM
15/11/13
TFCChairman's Address - AGM
15/11/13
TFCAppointment of New Chief Financial Officer
12/11/13
TFCWithdrawal of Resolution 3 - Performance Rights Plan
11/11/13
TFCAppendix 3B
08/11/13
TFCWholesale Settlement of $49 million
25/10/13PRICE SENSITIVE
TFCPresentation to Australian Microcap Investment Conference
22/10/13
TFCCeasing to be a substantial holder
10/10/13
TFCAnnual General Meeting and Notice
10/10/13
TFCNotice of Annual General Meeting/Proxy Form
09/10/13
TFCAnnual Report to shareholders
07/10/13
TFCHarvest and Pharmaceutical Development Update
01/10/13PRICE SENSITIVE
TFCInitial Director's Interest Notice x1
17/09/13
TFCIndependent Non - Executive Chairman Commences with TFS
17/09/13
TFCAnnual Financial Statements
13/09/13
TFCFIRST HARVEST UPDATE
09/09/13PRICE SENSITIVE
TFCInvestor Presentation
02/09/13
TFCNON-EXECUTIVE CHAIRMAN APPOINTMENT
29/08/13
TFCFIRST HARVEST UPDATE
29/08/13PRICE SENSITIVE
TFCPROFIT INCREASE & DIVIDEND REINSTATED
29/08/13
TFCPreliminary Financial Report for the year ended 30 June 2013
29/08/13PRICE SENSITIVE
TFCChange in substantial holding
23/07/13
TFCAppendix 3Y - Change of Director's Interest Notice
03/07/13
TFCAmended Share Trading Policy
02/07/13
TFCSales up 132% and Strategic Review Outcomes
02/07/13PRICE SENSITIVE
TFCUS Institution Exercises Second Option
27/06/13PRICE SENSITIVE
TFCMarket Update
26/06/13PRICE SENSITIVE
TFCAppendix 3Y - Change of Director's Interest Notice
06/06/13
TFCResponse to ASX Price and Volume Query
05/06/13PRICE SENSITIVE
TFCUn-audited Financial Report for the 9 months ended 31.03.13
31/05/13
TFCUNAUDITED FINANCIAL RESULTS FOR THE 9 MONTHS ENDING 31.03.13
31/05/13PRICE SENSITIVE
TFCAppendix 3Y - Change of Director's Interest Notice
14/05/13
TFCDivestment of Portfolio of MIS Loans
01/05/13
TFCBecoming a substantial holder
12/04/13
TFCPharmaceutical Product Development with US Partners
11/04/13PRICE SENSITIVE
TFCMarket Update
21/03/13PRICE SENSITIVE
TFCIndustry Leader for Ethical and Sustainable Practice
13/03/13
TFCHalf Year Financial Results and Market Update
28/02/13
TFCAppendix 4D - Half Year Financial Report
28/02/13PRICE SENSITIVE
TFCAppendix 3Y - Change of Director's Interest Notice
30/01/13
TFCAppendix 3Y - Change of Director's Interest Notice
23/01/13
TFCMarket Update
16/01/13PRICE SENSITIVE
TFCAppendix 3Y - Change of Director's Interest Notice
14/01/13
TFCShareholder Update
20/12/12PRICE SENSITIVE
TFCMIS Product Ruling for 2013
12/12/12
TFCMarket Update
03/12/12PRICE SENSITIVE
TFCUnaudited September Quarter Results
03/12/12PRICE SENSITIVE
TFCUnaudited Quarterly Financial Report - Quarter Ended 300912
03/12/12
TFCExtract of AGM Chairman's Address
16/11/12PRICE SENSITIVE
TFCResults of Meeting
16/11/12
TFCRequisition Notice
12/11/12PRICE SENSITIVE
TFCAppendix 3Y - Change of Director's Interest Notice
18/10/12
TFCNotice of Annual General Meeting/Proxy Form
17/10/12
TFCAppendix 3Z Final Directors Interest Notice
03/10/12
TFCRESIGNATION OF CHAIRMAN
03/10/12
TFCUpdated Investor Presentation
02/10/12
TFC2012 Annual Report
28/09/12
TFCInvestor Presentation
13/09/12
TFCBOARD APPOINT MOELIS & COMPANY TO ASSIST ON STRATEGIC REVIEW
06/09/12
TFCFULL YEAR RESULTS TO 30 JUNE 2012 AND MARKET UPDATE
31/08/12PRICE SENSITIVE
TFCAPPENDIX 4E - Preliminary Financial Report
31/08/12PRICE SENSITIVE
TFCAppendix 3X - Initial Director's Interest Notice
12/07/12
TFCAppendix 3Z - Final Director's Interest Notice
12/07/12
TFCAppendix 3Z - Final Director's Interest Notice
12/07/12
TFCTFS DIRECTOR MOVEMENTS AND WHOLESALE SETTLEMENT
12/07/12
TFCMIS SALES RESULT
02/07/12PRICE SENSITIVE
TFCRELEASE OF FUNDS IN ESCROW
26/06/12
TFCAppendix 3X - Initial Director's Interest Notice
14/06/12
TFCChanges to the Board of Directors
14/06/12
TFCChange in substantial holding
05/06/12
TFCUn-audited Financial Report for the 9 months ended 31 Mar 12
30/05/12PRICE SENSITIVE
TFCTFS REPORTS UNAUDITED FINANCIAL RESULTS - MARCH QUARTER FY12
30/05/12PRICE SENSITIVE
TFCMARKET UPDATE
21/03/12PRICE SENSITIVE
TFCAppendix 3Y
02/03/12
TFCChange of Director's Interest Notice
01/03/12
TFC1H12 Results Presentation
29/02/12
TFCAPPENDIX 4D - Half Year Financial Report
29/02/12PRICE SENSITIVE
TFCHALF YEAR RESULTS TO 31 DECEMBER 2011
29/02/12
TFCFURTHER LAND ACQUISITIONS AND UPDATE
20/01/12PRICE SENSITIVE
TFCMarket Update
03/01/12PRICE SENSITIVE
TFCAppendix 3X - J Matthys
03/01/12
TFCAppendix 3Z - J Craig
03/01/12
TFCTFS ViroXis Update
28/12/11PRICE SENSITIVE
TFCFURTHER LAND ACQUISITIONS AND BOARD CHANGES
23/12/11PRICE SENSITIVE
TFCTFS REPORTS UNAUDITED SEPTEMBER QUARTER FINANCIAL RESULTS
30/11/11
TFCUn-audited September 2011 Quarterly Financial Report
30/11/11PRICE SENSITIVE
TFCChange in substantial holding
16/11/11
refresh Created with Sketch. REFRESH
 

Top Stories

Chaos reigns markets – so let's take stock of where we're at ahead of December

For many people, it feels like the world has been getting crazier each year since 2020 (or 2016.) It's likely to continue
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.